Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.350
+0.120 (9.76%)
At close: Sep 18, 2026, 4:00 PM EDT
1.306
-0.044 (-3.24%)
After-hours: Sep 18, 2026, 7:35 PM EDT
Coherus Oncology Employees
Coherus Oncology had 144 employees as of June 30, 2026. The number of employees decreased by 33 or -18.64% compared to the same quarter last year.
Employees
144
Change
-33
Growth
-18.64%
Revenue / Employee
$353,722
Profits / Employee
-$917,583
Market Cap
208.58M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 144 | -33 | -18.64% |
| Mar 31, 2026 | 145 | -76 | -34.39% |
| Dec 31, 2025 | 147 | -81 | -35.53% |
| Sep 30, 2025 | 158 | -77 | -32.77% |
| Jun 30, 2025 | 177 | -69 | -28.05% |
| Mar 31, 2025 | 221 | -28 | -11.24% |
| Dec 31, 2024 | 228 | -78 | -25.49% |
| Sep 30, 2024 | 235 | -64 | -21.40% |
| Jun 30, 2024 | 246 | -48 | -16.33% |
| Mar 31, 2024 | 249 | -58 | -18.89% |
| Dec 31, 2023 | 306 | -53 | -14.76% |
| Sep 30, 2023 | 299 | -77 | -20.48% |
| Jun 30, 2023 | 294 | -74 | -20.11% |
| Mar 31, 2023 | 307 | -39 | -11.27% |
| Dec 31, 2022 | 359 | 27 | 8.13% |
| Sep 30, 2022 | 376 | 42 | 12.57% |
| Jun 30, 2022 | 368 | 57 | 18.33% |
| Mar 31, 2022 | 346 | 36 | 11.61% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Protalix BioTherapeutics | 226 |
| Nkarta | 106 |
| Alector | 103 |
| PepGen | 57 |
| Protara Therapeutics | 46 |
| Eledon Pharmaceuticals | 33 |
| Sol-Gel Technologies | 28 |
| Satellos Bioscience | 21 |
CHRS News
- 3 days ago - Coherus Oncology Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 4 days ago - Coherus Oncology Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 4 days ago - Coherus Oncology Transcript: 2026 Global Healthcare Conference - Transcripts
- 19 days ago - Coherus to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Coherus Oncology issuing special dividend of biosimilar contingent value rights - TheFly
- 4 weeks ago - Coherus Oncology Announces Special Dividend of Biosimilar Contingent Value Rights - GlobeNewsWire
- 6 weeks ago - Coherus Oncology price target lowered to $10 from $12 at Guggenheim - TheFly
- 6 weeks ago - Coherus Oncology reports Q2 EPS (19c), consensus (12c) - TheFly